Aging Successfully: The Role of Genetics and Environment in the Era of the Aging-Boom. Potential Therapeutic Implications

Author(s): Anna Aiello, Giulia Accardi.

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 39 , 2019

Become EABM
Become Reviewer

[1]
Global Health Observatory (GHO) data. [update 2019]. Available from: www.who.int
[2]
Martinson M, Berridge C. Successful aging and its discontents: a systematic review of the social gerontology literature. Gerontologist 2015; 55: 58-69.
[3]
Bowling A, Dieppe P. What is successful ageing and who should define it? BMJ 2005; 331: 1548-51.
[4]
Ageing and life-course. [update 2019]. Available from: www.who.it
[5]
Genetics of healthy aging and longevity Angela R. Brooks-Wilson Hum Genet 2013; 132: 1323-38.
[6]
Accardi G, Aprile S, Candore G, et al. Genotypic and phenotypic aspects of longevity: results from a sicilian survey and implication for the prevention and treatment of age-related diseases. Curr Pharm Des 2019; 25: 228-35.
[7]
Caruso C, Aiello A, Accardi G, Ciaglia E, Cattaneo M, Puca A. Genetic signatures of centenarians: implications for achieving successful ageing. Curr Pharm Des 2019; 25(39): 4133-8.
[8]
Guarasci F, D’Aquila P, Montesanto A, Corsonello A, Bellizzi D, Passarino G. Individual DNA methylation profile is correlated with age and can be targeted to modulate healthy aging and longevity. Curr Pharm Des 2019; 25(39): 4139-49.
[9]
Cammarata G, Duro G, Di Chiara T, Lo Curto A, Taverna S, Candore G. Circulating miRNAs in successful and unsuccessful aging. A mini-review. Curr Pharm Des 2019; 25(39): 4150-3.
[10]
Witkowski JM, Bryl E, Fulop T. Should we try to alleviate the immunosenescence and inflammaging - why, how and to what extent? Curr Pharm Des 2019; 25(39): 4154-62.
[11]
Zareian N, Aprile S, Cristaldi L, Ligotti ME, Vasto S, Farzaneh F. Triggering of Toll-like receptors in old individuals. Relevance for vaccination. Curr Pharm Des 2019; 25(39): 4163-7.
[12]
Gambino CM, Lo Sasso B, Bivona G, Agnello L, Ciaccio M. Aging and neuroinflammatory disorders: new biomarkers and therapeutic targets. Curr Pharm Des 2019; 25(39): 4168-74.
[13]
Mangoni AA, Tommasi S, Zinellu A, et al. Methotrexate and vasculoprotection: mechanistic insights and potential therapeutic applications in old age. Curr Pharm Des 2019; 25(39): 4175-84.
[14]
Scuderi L, Davinelli S, Iodice CM, et al. Melatonin: implications for ocular disease and therapeutic potential. Curr Pharm Des 2019; 25(39): 4185-91.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 39
Year: 2019
Page: [4131 - 4132]
Pages: 2
DOI: 10.2174/138161282539191226114927

Article Metrics

PDF: 20
HTML: 3
PRC: 1